Parenteral Iron Replacement [EPC]

Parenteral Iron Replacement [EPC] was reported 13741 times

Drugs of the Parenteral Iron Replacement [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 APPENDICOLITH 260 0.6718
1 SLEEP DISORDER THERAPY 101 0.5101
2 ANTACID THERAPY 52 0.4000
3 ANALGESIC THERAPY 102 0.3178
4 DRUG THERAPY 95 0.2802
5 VESSEL PUNCTURE SITE INFLAMMATION 9 0.2308
6 ANORECTAL ULCER 8 0.2222
7 ANTICOAGULANT THERAPY 49 0.1725
8 FISHBANE REACTION 13 0.1667
9 BACTEROIDES INFECTION 38 0.1456
10 CONGENITAL HIATUS HERNIA 32 0.1404
11 MALIGNANT MELANOMA STAGE 0 27 0.1292
12 NON-CONSUMMATION 8 0.1081
13 SHUNT STENOSIS 24 0.0866
14 ADMINISTRATION SITE DISCOLOURATION 10 0.0800
15 BLOOD PHOSPHORUS INCREASED 199 0.0728
16 HYPERPHOSPHATAEMIA 145 0.0674
17 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 16 0.0637
18 SHUNT OCCLUSION 30 0.0591
19 HAEMODIALYSIS COMPLICATION 10 0.0588
20 AGONAL RESPIRATION 16 0.0565
21 INFUSION SITE DISCOLOURATION 45 0.0511
22 GRANULOMA SKIN 39 0.0475
23 EXTRAVASATION 193 0.0469
24 SKIN FIBROSIS 22 0.0455
25 INJECTION SITE PHLEBITIS 10 0.0427
26 NEPHROGENIC SYSTEMIC FIBROSIS 122 0.0403
27 INFUSION SITE PHLEBITIS 9 0.0395
28 TRANSFERRIN SATURATION INCREASED 13 0.0378
29 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 32 0.0345
30 IRON DEFICIENCY 155 0.0344
31 INFUSION SITE THROMBOSIS 9 0.0336
32 SUPERFICIAL VEIN THROMBOSIS 28 0.0333
33 EXTREMITY CONTRACTURE 21 0.0328
34 IRON OVERLOAD 34 0.0315
35 LOSS OF EMPLOYMENT 95 0.0314
36 TOTAL LUNG CAPACITY DECREASED 48 0.0300
37 BLOOD PARATHYROID HORMONE DECREASED 43 0.0290
38 APPENDICITIS 267 0.0286
39 SKIN INDURATION 58 0.0280
40 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 29 0.0273
41 JOINT CONTRACTURE 29 0.0270
42 GASTROINTESTINAL VASCULAR MALFORMATION HAEMORRHAGIC 10 0.0267
43 BLOOD URIC ACID INCREASED 150 0.0260
44 BACTERIAL TRANSLOCATION 8 0.0252
45 HYPOPHOSPHATAEMIA 182 0.0246
46 INJECTION SITE THROMBOSIS 8 0.0244
47 EYE ROLLING 17 0.0240
48 HYPERPARATHYROIDISM SECONDARY 60 0.0239
49 AORTIC STENOSIS 82 0.0235
50 INTRAVASCULAR HAEMOLYSIS 13 0.0232
51 VENTRICULAR FIBRILLATION 246 0.0221
52 SKIN HYPERTROPHY 59 0.0210
53 ARTERIOVENOUS FISTULA THROMBOSIS 7 0.0202
54 DIALYSIS RELATED COMPLICATION 7 0.0198
55 NEPHROGENIC ANAEMIA 90 0.0194
56 INFUSION SITE URTICARIA 13 0.0194
57 ANGIODYSPLASIA 7 0.0192
58 PULSE ABSENT 91 0.0191
59 SERUM FERRITIN DECREASED 33 0.0191
60 MYASTHENIA GRAVIS 154 0.0190
61 INFUSION SITE EXTRAVASATION 118 0.0189
62 CARDIOGENIC SHOCK 270 0.0188
63 TRANSFERRIN SATURATION DECREASED 8 0.0187
64 LIVEDO RETICULARIS 39 0.0187
65 C-REACTIVE PROTEIN DECREASED 12 0.0184
66 ANAPHYLACTOID REACTION 74 0.0180
67 INFUSION SITE OEDEMA 15 0.0179
68 PULSE PRESSURE DECREASED 9 0.0176
69 LUNG OPACITY 46 0.0174
70 APLASIA PURE RED CELL 60 0.0174
71 PANNICULITIS 41 0.0169
72 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 85 0.0168
73 SKIN TIGHTNESS 75 0.0159
74 BLOOD PRESSURE IMMEASURABLE 24 0.0157
75 SERRATIA INFECTION 11 0.0148
76 RHEUMATOID NODULE 40 0.0145
77 BREATH SOUNDS ABNORMAL 71 0.0144
78 THROMBOPHLEBITIS SUPERFICIAL 43 0.0142
79 DRUG TOLERANCE DECREASED 39 0.0139
80 UNRESPONSIVE TO STIMULI 347 0.0134
81 INFUSION RELATED REACTION 869 0.0131
82 FOETAL HYPOKINESIA 9 0.0128
83 LYMPHANGITIS 10 0.0124
84 ARTERIOVENOUS FISTULA SITE COMPLICATION 7 0.0117
85 DISCOLOURED VOMIT 11 0.0114
86 FIBROSIS 35 0.0114
87 PLEURITIC PAIN 31 0.0112
88 GASTROINTESTINAL SCARRING 8 0.0110
89 SERUM FERRITIN INCREASED 58 0.0110
90 END STAGE RENAL DISEASE 197 0.0108
91 PULSE ABNORMAL 25 0.0104
92 TROPONIN INCREASED 76 0.0100
93 MULTIPLE ORGAN DYSFUNCTION SYNDROME 278 0.0098
94 CALCIPHYLAXIS 18 0.0098
95 ASCITES 286 0.0097
96 BLOOD IRON INCREASED 18 0.0096
97 SEIZURE LIKE PHENOMENA 16 0.0094
98 ADMINISTRATION SITE EXTRAVASATION 9 0.0090
99 VEIN RUPTURE 15 0.0090
100 INFUSION SITE RASH 12 0.0087
101 INCORRECT DRUG ADMINISTRATION RATE 37 0.0087
102 SKIN NECROSIS 45 0.0087
103 IRON DEFICIENCY ANAEMIA 80 0.0087
104 BACTERIAL INFECTION 161 0.0086
105 PHLEBITIS 44 0.0086
106 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 147 0.0086
107 RESUSCITATION 14 0.0084
108 BLOOD PARATHYROID HORMONE INCREASED 24 0.0082
109 ANAPHYLACTIC REACTION 453 0.0082
110 INFUSION SITE WARMTH 10 0.0082
111 UTERINE CONTRACTIONS DURING PREGNANCY 8 0.0078
112 ULCER 122 0.0077
113 INCISION SITE PAIN 9 0.0077
114 RHEUMATOID FACTOR POSITIVE 44 0.0076
115 INFUSION SITE PAIN 98 0.0076
116 PREMATURE RUPTURE OF MEMBRANES 18 0.0075
117 TOXOPLASMOSIS 8 0.0074
118 HEPATIC STEATOSIS 137 0.0073
119 RESPIRATORY SYMPTOM 20 0.0070
120 FEMALE GENITAL TRACT FISTULA 12 0.0070
121 FAECAL INCONTINENCE 33 0.0069
122 BICYTOPENIA 13 0.0066
123 BLOOD CALCIUM INCREASED 58 0.0066
124 PALLOR 179 0.0066
125 THROMBOPHLEBITIS 23 0.0066
126 INFUSION SITE SWELLING 41 0.0065
127 XEROSIS 8 0.0065
128 NEURALGIA 155 0.0064
129 HYPERLIPIDAEMIA 76 0.0064
130 HYPERPARATHYROIDISM 13 0.0063
131 STARING 15 0.0062
132 DRUG MONITORING PROCEDURE NOT PERFORMED 11 0.0061
133 ADMINISTRATION SITE PAIN 7 0.0061
134 FOAMING AT MOUTH 12 0.0059
135 BLOOD PRESSURE SYSTOLIC DECREASED 27 0.0059
136 VENOUS THROMBOSIS 23 0.0059
137 OSTEOMALACIA 9 0.0058
138 PAINFUL RESPIRATION 14 0.0058
139 BLOOD PHOSPHORUS DECREASED 21 0.0057
140 INCORRECT PRODUCT ADMINISTRATION DURATION 124 0.0057
141 BLOOD PRESSURE DECREASED 362 0.0054
142 BENIGN PROSTATIC HYPERPLASIA 28 0.0054
143 MUSCLE CONTRACTURE 11 0.0054
144 FLUSHING 550 0.0054
145 CYANOSIS 85 0.0054
146 VENOUS THROMBOSIS LIMB 11 0.0053
147 HYPONATRAEMIA 291 0.0052
148 CONTRAINDICATED PRODUCT ADMINISTERED 156 0.0051
149 INFUSION SITE BRUISING 11 0.0051
150 THROAT TIGHTNESS 137 0.0051
151 CHEST DISCOMFORT 516 0.0050
152 HYPERVENTILATION 29 0.0050
153 INFUSION SITE ERYTHEMA 42 0.0050
154 HYPOTENSION 938 0.0047
155 HAEMOLYSIS 36 0.0047
156 NORMOCHROMIC NORMOCYTIC ANAEMIA 14 0.0047
157 INJECTION SITE OEDEMA 8 0.0047
158 GOUT 82 0.0046
159 CLOSTRIDIUM TEST POSITIVE 10 0.0045
160 HAEMODIALYSIS 38 0.0045
161 LARGE INTESTINAL STENOSIS 9 0.0045
162 FEELING HOT 276 0.0045
163 INDURATION 8 0.0045
164 DEVICE RELATED SEPSIS 9 0.0045
165 INFUSION SITE REACTION 13 0.0043
166 BURNING SENSATION 302 0.0043
167 BLOOD IRON DECREASED 51 0.0043
168 HYPERCALCAEMIA 53 0.0043
169 URTICARIA 715 0.0043
170 BLOOD CALCIUM ABNORMAL 7 0.0042
171 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 16 0.0042
172 RENAL FAILURE CHRONIC 32 0.0042
173 COLD SWEAT 73 0.0041
174 RALES 24 0.0041
175 SKIN DISCOLOURATION 189 0.0041
176 STRIDOR 12 0.0041
177 PULSELESS ELECTRICAL ACTIVITY 17 0.0041
178 BLOOD TEST ABNORMAL 57 0.0041
179 FLANK PAIN 38 0.0040
180 HYPOPNOEA 14 0.0040
181 METABOLIC ENCEPHALOPATHY 12 0.0040
182 MIXED LIVER INJURY 12 0.0040
183 RED BLOOD CELL SEDIMENTATION RATE INCREASED 44 0.0040
184 SMALL INTESTINAL HAEMORRHAGE 8 0.0040
185 COMPLICATIONS OF TRANSPLANTED KIDNEY 9 0.0040
186 PRODUCT PREPARATION ISSUE 26 0.0040
187 RESPIRATORY DISTRESS 109 0.0039
188 PRESYNCOPE 96 0.0039
189 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 16 0.0039
190 METHAEMOGLOBINAEMIA 9 0.0039
191 JOINT RANGE OF MOTION DECREASED 52 0.0039
192 RENAL TRANSPLANT 14 0.0039
193 RESPIRATORY RATE INCREASED 34 0.0038
194 INFUSION SITE PRURITUS 12 0.0038
195 ABDOMINAL PAIN 879 0.0038
196 ABDOMINAL MASS 10 0.0037
197 HYPERHIDROSIS 480 0.0037
198 PULMONARY FIBROSIS 71 0.0037
199 PERIORBITAL OEDEMA 19 0.0037
200 SEPSIS 407 0.0036
201 INFLAMMATORY MARKER INCREASED 18 0.0036
202 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 28 0.0036
203 MICTURITION URGENCY 41 0.0036
204 JOINT STIFFNESS 94 0.0036
205 DEFORMITY 33 0.0035
206 THERAPEUTIC PRODUCT EFFECT DECREASED 158 0.0035
207 TACHYCARDIA 313 0.0035
208 PREMATURE DELIVERY 55 0.0035
209 ABDOMINAL DISTENSION 358 0.0034
210 HAEMOGLOBIN ABNORMAL 22 0.0034
211 PARAESTHESIA ORAL 49 0.0034
212 DIALYSIS 48 0.0034
213 BLOOD CHOLESTEROL INCREASED 157 0.0034
214 BODY TEMPERATURE FLUCTUATION 7 0.0034
215 POLYP 22 0.0034
216 BLOOD CULTURE POSITIVE 10 0.0033
217 SWELLING 310 0.0033
218 DYSPNOEA 1869 0.0033
219 OEDEMA PERIPHERAL 402 0.0033
220 ASPIRATION 36 0.0033
221 CEREBRAL HAEMATOMA 11 0.0033
222 HYPERVOLAEMIA 16 0.0032
223 SKIN PLAQUE 27 0.0032
224 VEIN DISORDER 16 0.0032
225 PERIPHERAL SWELLING 491 0.0032
226 SYSTEMIC CANDIDA 8 0.0032
227 DIABETIC NEPHROPATHY 7 0.0032
228 DRUG INTOLERANCE 307 0.0032
229 FLUID OVERLOAD 46 0.0032
230 GENERAL PHYSICAL HEALTH DETERIORATION 365 0.0032
231 BLOOD ALBUMIN DECREASED 25 0.0031
232 HYPERSENSITIVITY 583 0.0031
233 BLOOD PRESSURE SYSTOLIC INCREASED 61 0.0031
234 BLOOD LOSS ANAEMIA 7 0.0031
235 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 161 0.0031
236 EYE MOVEMENT DISORDER 21 0.0031
237 CARDIO-RESPIRATORY ARREST 127 0.0030
238 ANAPHYLACTIC SHOCK 78 0.0030
239 HYPERTHERMIA 23 0.0030
240 CYTOLYTIC HEPATITIS 10 0.0030
241 POTENTIATING DRUG INTERACTION 10 0.0030
242 MUSCLE TIGHTNESS 48 0.0030
243 APNOEA 23 0.0030
244 SYNCOPE 295 0.0029
245 BACK PAIN 681 0.0029
246 SKIN WARM 17 0.0029
247 BRONCHOPNEUMONIA 10 0.0029
248 CHEST PAIN 540 0.0029
249 PRODUCT AVAILABILITY ISSUE 66 0.0029
250 ACUTE CORONARY SYNDROME 24 0.0029
251 BASAL CELL CARCINOMA 45 0.0029
252 CAROTID ARTERY STENOSIS 10 0.0029
253 ERYTHEMA NODOSUM 10 0.0028
254 INJECTION SITE EXTRAVASATION 35 0.0028
255 BRONCHIECTASIS 19 0.0028
256 FIBRIN D DIMER INCREASED 10 0.0028
257 OXYGEN SATURATION DECREASED 158 0.0028
258 LOCALISED OEDEMA 13 0.0028
259 FOETAL GROWTH RESTRICTION 17 0.0028
260 RESPIRATORY ARREST 77 0.0028
261 SKIN HYPERPIGMENTATION 24 0.0028
262 SKIN ULCER 72 0.0028
263 PEMPHIGOID 21 0.0028
264 PARAESTHESIA 437 0.0028
265 LUNG CANCER METASTATIC 8 0.0028
266 LOW BIRTH WEIGHT BABY 22 0.0028
267 HYPOVOLAEMIA 16 0.0027
268 ENDOCARDITIS 14 0.0027
269 INJECTION SITE DISCOLOURATION 34 0.0027
270 ARTERIOSCLEROSIS CORONARY ARTERY 18 0.0027
271 VITAMIN B12 DEFICIENCY 11 0.0027
272 FOETAL DEATH 14 0.0027
273 MALNUTRITION 30 0.0027
274 LOSS OF CONSCIOUSNESS 343 0.0027
275 REBOUND ACID HYPERSECRETION 8 0.0026
276 VOMITING 1238 0.0026
277 INTERNATIONAL NORMALISED RATIO ABNORMAL 9 0.0026
278 ANAL FISSURE 14 0.0026
279 PRESCRIBED UNDERDOSE 52 0.0026
280 LARYNGEAL OEDEMA 16 0.0026
281 DRUG ERUPTION 46 0.0026
282 HYPOCALCAEMIA 49 0.0026
283 ATELECTASIS 25 0.0026
284 TOXIC EPIDERMAL NECROLYSIS 39 0.0026
285 ANAEMIA 489 0.0026
286 MUSCULOSKELETAL STIFFNESS 223 0.0025
287 HEPATIC LESION 11 0.0025
288 THROAT IRRITATION 114 0.0025
289 DRY MOUTH 206 0.0025
290 FAECES DISCOLOURED 55 0.0025
291 SPUTUM DISCOLOURED 24 0.0025
292 FAECAL CALPROTECTIN INCREASED 8 0.0025
293 DIVERTICULUM INTESTINAL 11 0.0025
294 POOR VENOUS ACCESS 26 0.0025
295 OESOPHAGEAL CANDIDIASIS 10 0.0025
296 HEART RATE DECREASED 88 0.0025
297 KIDNEY TRANSPLANT REJECTION 12 0.0025
298 ACUTE PULMONARY OEDEMA 14 0.0025
299 CHILLS 292 0.0025
300 CAESAREAN SECTION 29 0.0025
301 HYPERTENSION 527 0.0025
302 HYPERCHOLESTEROLAEMIA 24 0.0025
303 SWOLLEN TONGUE 77 0.0025
304 THROMBOSIS 198 0.0025
305 DIARRHOEA HAEMORRHAGIC 23 0.0025
306 FULL BLOOD COUNT ABNORMAL 26 0.0025
307 MATERNAL EXPOSURE DURING PREGNANCY 219 0.0025
308 PHARYNGEAL SWELLING 24 0.0025
309 CLOSTRIDIUM DIFFICILE COLITIS 26 0.0024
310 REFUSAL OF TREATMENT BY PATIENT 16 0.0024
311 THROMBOSIS IN DEVICE 8 0.0024
312 RETCHING 52 0.0024
313 DEFAECATION URGENCY 17 0.0024
314 GENERALISED OEDEMA 30 0.0024
315 HYPOXIA 85 0.0024
316 CARDIAC ARREST 198 0.0024
317 HAEMOGLOBIN DECREASED 246 0.0024
318 CARDIAC FAILURE CONGESTIVE 192 0.0024
319 PERITONITIS BACTERIAL 24 0.0024
320 URINARY INCONTINENCE 70 0.0024
321 DIABETES MELLITUS 179 0.0023
322 ABSCESS LIMB 10 0.0023
323 BRAIN HERNIATION 7 0.0023
324 ERYTHEMA 481 0.0023
325 ADVERSE REACTION 31 0.0023
326 BRONCHOSPASM 33 0.0023
327 OCULAR ICTERUS 10 0.0023
328 LIVER DISORDER 102 0.0023
329 MALABSORPTION 12 0.0023
330 ENTEROCOCCAL INFECTION 11 0.0023
331 PULMONARY EMBOLISM 216 0.0023
332 NAUSEA 1789 0.0023
333 PERIPHERAL COLDNESS 31 0.0023
334 EXPOSURE DURING PREGNANCY 140 0.0023
335 LIP SWELLING 75 0.0022
336 PRURITUS 862 0.0022
337 ARTERIOSCLEROSIS 21 0.0022
338 C-REACTIVE PROTEIN INCREASED 81 0.0022
339 GASTROINTESTINAL SOUNDS ABNORMAL 11 0.0022
340 SYNOVITIS 40 0.0022
341 ABDOMINAL TENDERNESS 11 0.0022
342 PLEURAL EFFUSION 132 0.0022
343 OBSTRUCTIVE AIRWAYS DISORDER 24 0.0022
344 GASTRITIS EROSIVE 10 0.0021
345 CHROMATURIA 48 0.0021
346 PERITONITIS 44 0.0021
347 FEELING COLD 59 0.0021
348 FAILURE TO THRIVE 11 0.0021
349 AORTIC VALVE INCOMPETENCE 9 0.0021
350 CATHETER SITE INFECTION 8 0.0021
351 ANAL INCONTINENCE 19 0.0021
352 SCAR 36 0.0021
353 ASPARTATE AMINOTRANSFERASE INCREASED 111 0.0021
354 SUPRAVENTRICULAR TACHYCARDIA 20 0.0021
355 MATERNAL DRUGS AFFECTING FOETUS 16 0.0021
356 INCONTINENCE 22 0.0021
357 PRURITUS GENERALISED 45 0.0021
358 COLITIS ISCHAEMIC 14 0.0021
359 STILLBIRTH 10 0.0021
360 SLEEP DISORDER 146 0.0021
361 ECCHYMOSIS 14 0.0020
362 ANAL ABSCESS 11 0.0020
363 NAIL DISCOLOURATION 8 0.0020
364 RASH MACULO-PAPULAR 45 0.0020
365 DEVICE RELATED INFECTION 31 0.0020
366 GASTRIC DISORDER 69 0.0020
367 INJECTION SITE INFLAMMATION 10 0.0020
368 ACUTE MYOCARDIAL INFARCTION 59 0.0020
369 HEART RATE INCREASED 198 0.0020
370 CIRCULATORY COLLAPSE 34 0.0020
371 VASCULAR DEVICE INFECTION 9 0.0020
372 CORONARY ARTERY DISEASE 60 0.0020
373 STEVENS-JOHNSON SYNDROME 44 0.0020
374 HAEMOGLOBIN INCREASED 9 0.0020
375 LIMB DISCOMFORT 61 0.0020
376 BLOOD UREA INCREASED 33 0.0020
377 HAEMATOCRIT DECREASED 39 0.0020
378 LIVER FUNCTION TEST INCREASED 42 0.0020
379 CACHEXIA 10 0.0019
380 WHEEZING 115 0.0019
381 BACTERAEMIA 23 0.0019
382 DERMATITIS BULLOUS 14 0.0019
383 UMBILICAL HERNIA 9 0.0019
384 ACUTE RESPIRATORY FAILURE 37 0.0019
385 BRADYCARDIA 102 0.0019
386 HEPATIC ENZYME INCREASED 130 0.0019
387 ENTEROCOLITIS 11 0.0019
388 CARDIAC FAILURE 152 0.0019
389 HYPERPYREXIA 8 0.0019
390 THERAPEUTIC RESPONSE DECREASED 114 0.0019
391 POOR PERIPHERAL CIRCULATION 8 0.0019
392 LUNG NEOPLASM 8 0.0019
393 CARDIOMEGALY 23 0.0019
394 HUMERUS FRACTURE 9 0.0019
395 PYELONEPHRITIS 16 0.0018
396 TACHYPNOEA 25 0.0018
397 ACIDOSIS 14 0.0018
398 CHRONIC KIDNEY DISEASE 138 0.0018
399 HYPERKERATOSIS 10 0.0018
400 RENAL PAIN 19 0.0018
401 CORONARY ARTERY STENOSIS 9 0.0018
402 SWELLING FACE 116 0.0018
403 SENSATION OF FOREIGN BODY 15 0.0018
404 PREMATURE LABOUR 10 0.0018
405 MOTOR DYSFUNCTION 18 0.0018
406 BLOOD PRESSURE DIASTOLIC DECREASED 13 0.0018
407 BLOOD PRESSURE INCREASED 269 0.0018
408 PSEUDOMONAS INFECTION 15 0.0017
409 PERIPHERAL VASCULAR DISORDER 9 0.0017
410 PULMONARY MASS 26 0.0017
411 RASH MACULAR 61 0.0017
412 GASTRIC ULCER 33 0.0017
413 POST PROCEDURAL HAEMORRHAGE 20 0.0017
414 BLOOD PRESSURE FLUCTUATION 41 0.0017
415 HYPERTENSIVE CRISIS 19 0.0017
416 JOINT SWELLING 206 0.0017
417 HYPOTONIA 17 0.0017
418 SUDDEN DEATH 18 0.0017
419 INTENTIONAL PRODUCT MISUSE 148 0.0017
420 SINUS TACHYCARDIA 24 0.0017
421 PHARYNGEAL OEDEMA 26 0.0017
422 GESTATIONAL DIABETES 8 0.0017
423 DIZZINESS 832 0.0017
424 TRANSAMINASES INCREASED 37 0.0017
425 NEUTROPHIL COUNT INCREASED 17 0.0017
426 LEUKOCYTOSIS 30 0.0017
427 FEBRILE BONE MARROW APLASIA 7 0.0016
428 FAECALOMA 9 0.0016
429 OEDEMA 89 0.0016
430 ANHEDONIA 43 0.0016
431 GASTROINTESTINAL DISORDER 146 0.0016
432 LOWER RESPIRATORY TRACT INFECTION 74 0.0016
433 GRAND MAL CONVULSION 15 0.0016
434 BLOOD CREATININE INCREASED 106 0.0016
435 CONSTIPATION 354 0.0016
436 ABDOMINAL PAIN UPPER 330 0.0016
437 HAEMORRHAGIC ANAEMIA 7 0.0016
438 HYPOAESTHESIA ORAL 24 0.0016
439 PURPURA 14 0.0016
440 BLOOD CREATINE INCREASED 7 0.0016
441 DRUG LEVEL DECREASED 16 0.0016
442 BODY TEMPERATURE INCREASED 32 0.0016
443 DEPRESSED LEVEL OF CONSCIOUSNESS 62 0.0016
444 HEPATITIS 40 0.0016
445 RASH 681 0.0016
446 HYPOAESTHESIA 233 0.0016
447 SINUS BRADYCARDIA 15 0.0016
448 DIVERTICULUM 11 0.0015
449 ABDOMINAL HERNIA 7 0.0015
450 ABDOMINAL DISCOMFORT 257 0.0015
451 RENAL TUBULAR NECROSIS 15 0.0015
452 ILEUS 19 0.0015
453 BLOOD LACTIC ACID INCREASED 8 0.0015
454 ECONOMIC PROBLEM 23 0.0015
455 BLOOD PRESSURE DIASTOLIC INCREASED 7 0.0015
456 ANGIOEDEMA 67 0.0015
457 FISTULA 17 0.0015
458 PERITONEAL DIALYSIS COMPLICATION 11 0.0015
459 HAEMOPTYSIS 42 0.0015
460 JOINT INJURY 32 0.0015
461 PRODUCT QUALITY ISSUE 203 0.0015
462 INFLAMMATION 77 0.0015
463 LOCAL SWELLING 26 0.0015
464 URINE OUTPUT DECREASED 13 0.0015
465 EOSINOPHILIA 26 0.0015
466 FACE OEDEMA 25 0.0015
467 MENTAL STATUS CHANGES 41 0.0015
468 LYMPHOCYTE COUNT DECREASED 26 0.0015
469 PERICARDIAL EFFUSION 34 0.0015
470 SKIN LESION 40 0.0015
471 SOMNOLENCE 293 0.0015
472 INTESTINAL ISCHAEMIA 8 0.0015
473 GASTROINTESTINAL INFECTION 13 0.0014
474 HAEMATOCHEZIA 80 0.0014
475 OROPHARYNGEAL DISCOMFORT 13 0.0014
476 HEART RATE ABNORMAL 8 0.0014
477 BODY TEMPERATURE DECREASED 14 0.0014
478 MITRAL VALVE INCOMPETENCE 16 0.0014
479 PROCTALGIA 9 0.0014
480 PREMATURE BABY 42 0.0014
481 NEPHROPATHY 13 0.0014
482 HAEMATOMA 36 0.0014
483 ANGINA UNSTABLE 9 0.0014
484 DRUG SPECIFIC ANTIBODY PRESENT 9 0.0014
485 ARTHRALGIA 573 0.0014
486 ILL-DEFINED DISORDER 83 0.0014
487 COUGH 383 0.0014
488 MUSCULOSKELETAL CHEST PAIN 21 0.0014
489 BLOOD POTASSIUM INCREASED 22 0.0014
490 CONDITION AGGRAVATED 409 0.0013
491 PETECHIAE 14 0.0013
492 CARDIOVASCULAR DISORDER 34 0.0013
493 WRONG PRODUCT ADMINISTERED 9 0.0013
494 RASH PRURITIC 72 0.0013
495 HYPOKALAEMIA 61 0.0013
496 LETHARGY 76 0.0013
497 PULMONARY OEDEMA 59 0.0013
498 HAEMODYNAMIC INSTABILITY 10 0.0013
499 BLOOD PRESSURE ABNORMAL 26 0.0013
500 SHOCK 30 0.0013
501 ATRIAL FIBRILLATION 127 0.0013
502 PLATELET COUNT INCREASED 17 0.0013
503 RECTAL HAEMORRHAGE 56 0.0013
504 SMALL INTESTINAL OBSTRUCTION 16 0.0013
505 MALAISE 568 0.0013
506 RASH PAPULAR 29 0.0013
507 FORMICATION 9 0.0013
508 RESTLESSNESS 47 0.0013
509 RESPIRATORY FAILURE 93 0.0013
510 VENTRICULAR TACHYCARDIA 21 0.0013
511 CHOKING SENSATION 7 0.0013
512 DRUG LEVEL BELOW THERAPEUTIC 7 0.0013
513 COAGULOPATHY 21 0.0013
514 TRICUSPID VALVE INCOMPETENCE 10 0.0013
515 RENAL FAILURE 167 0.0013
516 GASTRITIS 33 0.0013
517 C-REACTIVE PROTEIN ABNORMAL 8 0.0012
518 SENSORY DISTURBANCE 20 0.0012
519 LUNG INFILTRATION 11 0.0012
520 CARDIAC FLUTTER 8 0.0012
521 GASTROENTERITIS 18 0.0012
522 VITAMIN D DEFICIENCY 12 0.0012
523 HAEMORRHOIDS 24 0.0012
524 TUBULOINTERSTITIAL NEPHRITIS 23 0.0012
525 MELAENA 27 0.0012
526 HEAVY MENSTRUAL BLEEDING 11 0.0012
527 HYPERAESTHESIA 10 0.0012
528 TRANSIENT ISCHAEMIC ATTACK 41 0.0012
529 PULMONARY CONGESTION 16 0.0012
530 TREMOR 201 0.0012
531 APPETITE DISORDER 8 0.0012
532 ARTHROPATHY 67 0.0012
533 ELECTROLYTE IMBALANCE 14 0.0012
534 EXOSTOSIS 11 0.0012
535 CARDIAC FAILURE ACUTE 8 0.0012
536 PNEUMONIA BACTERIAL 11 0.0012
537 HYPERKALAEMIA 42 0.0012
538 LIVE BIRTH 10 0.0012
539 SEPTIC SHOCK 52 0.0012
540 UROSEPSIS 11 0.0012
541 PALPITATIONS 139 0.0012
542 DEAFNESS 31 0.0012
543 AGRANULOCYTOSIS 22 0.0012
544 MOBILITY DECREASED 85 0.0012
545 AORTIC ANEURYSM 9 0.0012
546 MATERNAL EXPOSURE BEFORE PREGNANCY 8 0.0012
547 UPPER RESPIRATORY TRACT INFECTION 54 0.0012
548 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 56 0.0012
549 ASTHENIA 437 0.0012
550 MUSCULOSKELETAL DISCOMFORT 20 0.0012
551 ARRHYTHMIA 55 0.0012
552 RESPIRATION ABNORMAL 8 0.0012
553 GASTROINTESTINAL HAEMORRHAGE 97 0.0012
554 SNEEZING 26 0.0012
555 DROOLING 8 0.0012
556 LARGE INTESTINE POLYP 8 0.0012
557 SKIN SWELLING 10 0.0012
558 CELLULITIS 58 0.0011
559 INGUINAL HERNIA 7 0.0011
560 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
561 WHITE BLOOD CELL COUNT INCREASED 44 0.0011
562 CLOSTRIDIUM DIFFICILE INFECTION 25 0.0011
563 TRANSFUSION 12 0.0011
564 RENAL INJURY 34 0.0011
565 PAIN IN EXTREMITY 336 0.0011
566 GRIP STRENGTH DECREASED 10 0.0011
567 OFF LABEL USE 989 0.0011
568 WRONG DRUG ADMINISTERED 10 0.0011
569 DIARRHOEA 724 0.0011
570 COLITIS ULCERATIVE 50 0.0011
571 SECRETION DISCHARGE 14 0.0011
572 FREQUENT BOWEL MOVEMENTS 30 0.0011
573 SPLENOMEGALY 13 0.0011
574 MUSCLE SPASMS 202 0.0011
575 HEPATIC CYTOLYSIS 14 0.0011
576 EMBOLISM 9 0.0011
577 LOWER GASTROINTESTINAL HAEMORRHAGE 8 0.0011
578 HEPATITIS ACUTE 7 0.0011
579 PYREXIA 372 0.0011
580 EAR DISCOMFORT 11 0.0011
581 HEPATIC ENCEPHALOPATHY 10 0.0011
582 BLOOD CALCIUM DECREASED 12 0.0011
583 THIRST 19 0.0011
584 METABOLIC ACIDOSIS 34 0.0011
585 RESPIRATORY DEPRESSION 13 0.0011
586 DISORIENTATION 42 0.0011
587 PULMONARY HYPERTENSION 22 0.0011
588 COLITIS 40 0.0011
589 ALANINE AMINOTRANSFERASE INCREASED 64 0.0010
590 RENAL FAILURE ACUTE 44 0.0010
591 CONVULSION 59 0.0010
592 APHTHOUS ULCER 8 0.0010
593 BRAIN OEDEMA 13 0.0010
594 DYSSTASIA 30 0.0010
595 ARTHRITIS 80 0.0010
596 HEADACHE 634 0.0010
597 UPPER GASTROINTESTINAL HAEMORRHAGE 17 0.0010
598 INTESTINAL OBSTRUCTION 38 0.0010
599 PRODUCT USE ISSUE 189 0.0010
600 HYPOMAGNESAEMIA 14 0.0010
601 PAIN 616 0.0010
602 MASS 14 0.0010
603 DEEP VEIN THROMBOSIS 65 0.0010
604 SENSORY LOSS 8 0.0010
605 TOXIC SKIN ERUPTION 10 0.0010
606 EMPHYSEMA 10 0.0010
607 SARS-COV-2 TEST POSITIVE 13 0.0010
608 NO THERAPEUTIC RESPONSE 12 0.0010
609 THROMBOCYTOPENIA 110 0.0010
610 ASPHYXIA 8 0.0010
611 HYPOPHAGIA 25 0.0010
612 ABNORMAL FAECES 8 0.0010
613 ORTHOSTATIC HYPOTENSION 17 0.0010
614 INTERVERTEBRAL DISC DEGENERATION 9 0.0010
615 PRODUCT USE IN UNAPPROVED INDICATION 240 0.0010
616 DISCOMFORT 59 0.0010
617 HEAD DISCOMFORT 17 0.0010
618 SKIN DISORDER 32 0.0010
619 HEPATIC CIRRHOSIS 18 0.0010
620 DYSPNOEA EXERTIONAL 36 0.0010
621 ADVERSE EVENT 88 0.0010
622 ACUTE KIDNEY INJURY 145 0.0009
623 HAEMATEMESIS 24 0.0009
624 ANXIETY 268 0.0009
625 RASH ERYTHEMATOUS 45 0.0009
626 ABSCESS 15 0.0009
627 DYSARTHRIA 35 0.0009
628 HEART RATE IRREGULAR 21 0.0009
629 ATAXIA 11 0.0009
630 MULTI-ORGAN FAILURE 16 0.0009
631 HYSTERECTOMY 8 0.0009
632 CHOLECYSTITIS 11 0.0009
633 MUSCLE RIGIDITY 11 0.0009
634 LYMPHOPENIA 13 0.0009
635 SEASONAL ALLERGY 13 0.0009
636 GROIN PAIN 8 0.0009
637 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 164 0.0009
638 STAPHYLOCOCCAL INFECTION 30 0.0009
639 IMMUNOSUPPRESSION 8 0.0009
640 BRAIN INJURY 9 0.0009
641 PULMONARY ARTERIAL HYPERTENSION 13 0.0009
642 QUALITY OF LIFE DECREASED 12 0.0009
643 GASTROOESOPHAGEAL REFLUX DISEASE 72 0.0009
644 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 23 0.0009
645 ABASIA 22 0.0009
646 HYPOTHERMIA 9 0.0009
647 SINUS CONGESTION 12 0.0009
648 MYALGIA 151 0.0009
649 DRUG EXPOSURE DURING PREGNANCY 30 0.0009
650 RESPIRATORY TRACT CONGESTION 14 0.0009
651 IMPAIRED GASTRIC EMPTYING 12 0.0009
652 MYOCARDIAL ISCHAEMIA 10 0.0009
653 LUNG DISORDER 43 0.0009
654 ATRIAL FLUTTER 7 0.0009
655 ALTERED STATE OF CONSCIOUSNESS 19 0.0009
656 INTERNATIONAL NORMALISED RATIO INCREASED 25 0.0009
657 FOETAL EXPOSURE DURING PREGNANCY 71 0.0009
658 TEMPERATURE INTOLERANCE 9 0.0009
659 TENDERNESS 9 0.0009
660 MUSCULAR WEAKNESS 98 0.0009
661 DECUBITUS ULCER 7 0.0009
662 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
663 HIATUS HERNIA 11 0.0008
664 INJECTION SITE INDURATION 11 0.0008
665 GENERALISED TONIC-CLONIC SEIZURE 14 0.0008
666 LEUKOPENIA 42 0.0008
667 SUBDURAL HAEMATOMA 12 0.0008
668 LUNG INFECTION 13 0.0008
669 FEELING ABNORMAL 200 0.0008
670 PERICARDITIS 14 0.0008
671 CHOLESTASIS 16 0.0008
672 ABDOMINAL PAIN LOWER 21 0.0008
673 DIZZINESS POSTURAL 8 0.0008
674 GASTROINTESTINAL PAIN 9 0.0008
675 NASAL CONGESTION 48 0.0008
676 HEPATOMEGALY 8 0.0008
677 SEIZURE 94 0.0008
678 PNEUMONIA 263 0.0008
679 RASH GENERALISED 21 0.0008
680 PREGNANCY 16 0.0008
681 ADVERSE DRUG REACTION 71 0.0008
682 HAEMATURIA 27 0.0008
683 BONE PAIN 46 0.0008
684 CYSTITIS 25 0.0008
685 HAEMOLYTIC ANAEMIA 7 0.0008
686 SKIN REACTION 11 0.0008
687 EYE SWELLING 29 0.0008
688 LABORATORY TEST ABNORMAL 23 0.0008
689 THERAPY NON-RESPONDER 35 0.0008
690 ANKLE FRACTURE 12 0.0008
691 CONFUSIONAL STATE 125 0.0008
692 RESPIRATORY TRACT INFECTION 20 0.0008
693 SKIN FISSURES 15 0.0008
694 NODULE 10 0.0008
695 APHASIA 23 0.0008
696 BLOOD THYROID STIMULATING HORMONE INCREASED 7 0.0008
697 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 54 0.0008
698 UNEVALUABLE EVENT 57 0.0008
699 DYSPHONIA 44 0.0008
700 RHABDOMYOLYSIS 31 0.0007
701 HOT FLUSH 56 0.0007
702 BURSITIS 9 0.0007
703 ADRENAL INSUFFICIENCY 9 0.0007
704 DECREASED ACTIVITY 8 0.0007
705 HYPERGLYCAEMIA 27 0.0007
706 CYTOPENIA 9 0.0007
707 PANCYTOPENIA 41 0.0007
708 ANGINA PECTORIS 21 0.0007
709 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
710 WOUND INFECTION 8 0.0007
711 BLOOD ALKALINE PHOSPHATASE INCREASED 18 0.0007
712 HERNIA 14 0.0007
713 HAIR COLOUR CHANGES 9 0.0007
714 HYPOGLYCAEMIA 35 0.0007
715 VISION BLURRED 99 0.0007
716 HYPOTHYROIDISM 23 0.0007
717 MEDICATION ERROR 40 0.0007
718 COORDINATION ABNORMAL 10 0.0007
719 WRONG TECHNIQUE IN DRUG USAGE PROCESS 26 0.0007
720 DERMATITIS ALLERGIC 9 0.0007
721 DYSGEUSIA 53 0.0007
722 FLUID RETENTION 36 0.0007
723 LYMPHADENOPATHY 25 0.0007
724 MUSCULOSKELETAL PAIN 37 0.0007
725 DYSPHAGIA 67 0.0007
726 INABILITY TO AFFORD MEDICATION 7 0.0007
727 SYSTEMIC LUPUS ERYTHEMATOSUS 25 0.0007
728 SCAB 8 0.0007
729 TREATMENT FAILURE 58 0.0007
730 HEPATIC FAILURE 21 0.0007
731 BLISTER 39 0.0007
732 PRODUCT ADMINISTRATION ERROR 14 0.0007
733 MYELODYSPLASTIC SYNDROME 10 0.0007
734 HYPOKINESIA 10 0.0007
735 DRY THROAT 7 0.0007
736 GAIT INABILITY 23 0.0007
737 VASCULITIS 8 0.0007
738 MOVEMENT DISORDER 22 0.0007
739 HELICOBACTER INFECTION 7 0.0007
740 PNEUMONIA ASPIRATION 17 0.0007
741 COLON CANCER 10 0.0007
742 DERMATITIS 14 0.0007
743 BLOOD BILIRUBIN INCREASED 18 0.0007
744 OSTEOMYELITIS 12 0.0007
745 FLATULENCE 37 0.0007
746 URINARY TRACT INFECTION 111 0.0007
747 SPEECH DISORDER 34 0.0006
748 WOUND 18 0.0006
749 AGITATION 47 0.0006
750 VERTIGO 39 0.0006
751 TREATMENT NONCOMPLIANCE 35 0.0006
752 ASTHMA 72 0.0006
753 FATIGUE 495 0.0006
754 FOOT FRACTURE 12 0.0006
755 NERVOUSNESS 33 0.0006
756 HAEMORRHAGE 66 0.0006
757 MUSCULOSKELETAL DISORDER 12 0.0006
758 INJECTION SITE IRRITATION 8 0.0006
759 OROPHARYNGEAL PAIN 58 0.0006
760 DECREASED APPETITE 145 0.0006
761 MYDRIASIS 8 0.0006
762 BRONCHITIS 46 0.0006
763 DIABETES MELLITUS INADEQUATE CONTROL 11 0.0006
764 INTENTIONAL PRODUCT USE ISSUE 54 0.0006
765 EMOTIONAL DISTRESS 74 0.0006
766 MENORRHAGIA 12 0.0006
767 GASTRIC HAEMORRHAGE 7 0.0006
768 PLATELET COUNT DECREASED 64 0.0006
769 EYE HAEMORRHAGE 8 0.0006
770 SPINAL FRACTURE 12 0.0006
771 DYSURIA 22 0.0006
772 RED BLOOD CELL COUNT DECREASED 17 0.0006
773 FEEDING DISORDER 12 0.0006
774 TASTE DISORDER 12 0.0006
775 NECK PAIN 33 0.0006
776 GAIT DISTURBANCE 113 0.0006
777 LIMB INJURY 16 0.0006
778 EPISTAXIS 44 0.0006
779 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
780 BLOOD URINE PRESENT 11 0.0006
781 DYSPEPSIA 57 0.0006
782 PROTEINURIA 11 0.0006
783 RHINORRHOEA 37 0.0006
784 RENAL IMPAIRMENT 48 0.0006
785 INJECTION SITE URTICARIA 14 0.0006
786 ENCEPHALOPATHY 14 0.0006
787 RESPIRATORY DISORDER 17 0.0006
788 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
789 DISEASE RECURRENCE 27 0.0006
790 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
791 HEPATOCELLULAR INJURY 8 0.0006
792 MUSCLE TWITCHING 13 0.0006
793 DEHYDRATION 75 0.0006
794 KIDNEY INFECTION 11 0.0006
795 GALLBLADDER DISORDER 10 0.0006
796 JAUNDICE 15 0.0006
797 PAIN OF SKIN 15 0.0006
798 IMPAIRED QUALITY OF LIFE 8 0.0006
799 INFECTION 80 0.0006
800 HYPERTHYROIDISM 8 0.0006
801 INJECTION SITE HAEMATOMA 8 0.0006
802 FULL BLOOD COUNT DECREASED 11 0.0005
803 DYSKINESIA 22 0.0005
804 HEPATOTOXICITY 12 0.0005
805 PRODUCT PREPARATION ERROR 11 0.0005
806 SKIN EXFOLIATION 45 0.0005
807 BEDRIDDEN 7 0.0005
808 BLOOD POTASSIUM DECREASED 16 0.0005
809 CEREBRAL INFARCTION 13 0.0005
810 WEIGHT DECREASED 148 0.0005
811 PAIN IN JAW 15 0.0005
812 INJURY 37 0.0005
813 SLEEP APNOEA SYNDROME 10 0.0005
814 HAIR TEXTURE ABNORMAL 7 0.0005
815 TINNITUS 24 0.0005
816 PANIC ATTACK 19 0.0005
817 DEATH 449 0.0005
818 BLOOD CREATINE PHOSPHOKINASE INCREASED 15 0.0005
819 POST PROCEDURAL COMPLICATION 10 0.0005
820 GINGIVAL BLEEDING 7 0.0005
821 VIRAL INFECTION 17 0.0005
822 CORONARY ARTERY OCCLUSION 7 0.0005
823 BRAIN FOG 8 0.0005
824 INJECTION SITE REACTION 35 0.0005
825 VAGINAL HAEMORRHAGE 22 0.0005
826 EYE PRURITUS 17 0.0005
827 OCULAR HYPERAEMIA 24 0.0005
828 PRODUCTIVE COUGH 24 0.0005
829 SCIATICA 8 0.0005
830 FALL 167 0.0005
831 HOSPITALISATION 77 0.0005
832 CARPAL TUNNEL SYNDROME 7 0.0005
833 CYTOKINE RELEASE SYNDROME 10 0.0005
834 TOOTHACHE 9 0.0005
835 LACRIMATION INCREASED 15 0.0005
836 FIBROMYALGIA 12 0.0005
837 BONE MARROW FAILURE 10 0.0005
838 PANCREATITIS ACUTE 11 0.0005
839 TOOTH LOSS 10 0.0005
840 NEPHROLITHIASIS 22 0.0005
841 BLOOD SODIUM DECREASED 9 0.0005
842 RHEUMATOID ARTHRITIS 54 0.0005
843 MOUTH ULCERATION 10 0.0005
844 INFLUENZA LIKE ILLNESS 39 0.0005
845 DRUG PRESCRIBING ERROR 9 0.0005
846 THERAPY CESSATION 24 0.0005
847 CONTUSION 45 0.0005
848 NEUTROPHIL COUNT DECREASED 19 0.0005
849 EAR PAIN 9 0.0005
850 NASOPHARYNGITIS 85 0.0005
851 MENTAL DISORDER 20 0.0005
852 EPILEPSY 14 0.0005
853 HYPERSOMNIA 13 0.0005
854 CATARACT 27 0.0005
855 FEBRILE NEUTROPENIA 30 0.0005
856 FEMUR FRACTURE 14 0.0005
857 LIVER FUNCTION TEST ABNORMAL 13 0.0004
858 FEAR 12 0.0004
859 PELVIC PAIN 8 0.0004
860 CRYING 16 0.0004
861 PROCEDURAL PAIN 12 0.0004
862 INJECTION SITE SWELLING 33 0.0004
863 RENAL DISORDER 20 0.0004
864 IMPAIRED HEALING 14 0.0004
865 DRUG LEVEL INCREASED 7 0.0004
866 NEUROPATHY PERIPHERAL 40 0.0004
867 FUNGAL INFECTION 14 0.0004
868 CEREBRAL HAEMORRHAGE 15 0.0004
869 MYOCARDIAL INFARCTION 73 0.0004
870 POOR QUALITY SLEEP 9 0.0004
871 ELECTROCARDIOGRAM QT PROLONGED 15 0.0004
872 INSOMNIA 111 0.0004
873 NERVOUS SYSTEM DISORDER 13 0.0004
874 ERUCTATION 8 0.0004
875 HEMIPARESIS 7 0.0004
876 NEUTROPENIA 56 0.0004
877 CHOKING 8 0.0004
878 LIVER INJURY 10 0.0004
879 ALOPECIA 80 0.0004
880 CEREBROVASCULAR ACCIDENT 69 0.0004
881 SKIN BURNING SENSATION 29 0.0004
882 HIP FRACTURE 13 0.0004
883 PNEUMONITIS 11 0.0004
884 UPPER LIMB FRACTURE 8 0.0004
885 AGEUSIA 10 0.0004
886 COVID-19 70 0.0004
887 THERAPEUTIC RESPONSE SHORTENED 13 0.0004
888 URINARY RETENTION 13 0.0004
889 OSTEOPOROSIS 16 0.0004
890 INJECTION SITE WARMTH 8 0.0004
891 ILLNESS 40 0.0004
892 GASTROENTERITIS VIRAL 7 0.0004
893 WHITE BLOOD CELL COUNT DECREASED 42 0.0004
894 COGNITIVE DISORDER 18 0.0004
895 BONE DISORDER 7 0.0004
896 ACCIDENTAL OVERDOSE 14 0.0004
897 BLOOD GLUCOSE INCREASED 72 0.0004
898 MUCOSAL INFLAMMATION 10 0.0004
899 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 27 0.0004
900 PANCREATITIS 20 0.0004
901 OSTEOARTHRITIS 16 0.0004
902 HEPATIC FUNCTION ABNORMAL 14 0.0004
903 IRRITABLE BOWEL SYNDROME 8 0.0004
904 LOCALISED INFECTION 9 0.0004
905 INTERSTITIAL LUNG DISEASE 18 0.0004
906 INJECTION SITE ERYTHEMA 46 0.0004
907 SINUSITIS 38 0.0004
908 WEIGHT INCREASED 83 0.0004
909 BALANCE DISORDER 32 0.0004
910 INCORRECT DOSE ADMINISTERED 84 0.0004
911 FEELING JITTERY 7 0.0004
912 THERAPY INTERRUPTED 26 0.0004
913 GLAUCOMA 7 0.0004
914 DIVERTICULITIS 10 0.0004
915 DRY SKIN 48 0.0004
916 COMA 17 0.0004
917 DISABILITY 7 0.0004
918 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
919 OVERDOSE 76 0.0004
920 ABORTION SPONTANEOUS 14 0.0003
921 DRUG INEFFECTIVE 460 0.0003
922 HERPES ZOSTER 20 0.0003
923 HEAD INJURY 11 0.0003
924 DISEASE PROGRESSION 41 0.0003
925 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
926 INCORRECT ROUTE OF DRUG ADMINISTRATION 12 0.0003
927 CHOLELITHIASIS 11 0.0003
928 ROAD TRAFFIC ACCIDENT 14 0.0003
929 IMPAIRED WORK ABILITY 7 0.0003
930 PRODUCT DOSE OMISSION ISSUE 96 0.0003
931 INJECTION SITE RASH 10 0.0003
932 INJECTION SITE BRUISING 26 0.0003
933 AMNESIA 21 0.0003
934 INJECTION SITE PAIN 98 0.0003
935 PRODUCT COMPLAINT 8 0.0003
936 INTENTIONAL DOSE OMISSION 9 0.0003
937 VISUAL IMPAIRMENT 39 0.0003
938 MIGRAINE 30 0.0003
939 INFLUENZA 35 0.0003
940 STOMATITIS 19 0.0003
941 DRUG INTERACTION 49 0.0003
942 DEPRESSION 69 0.0003
943 UNDERDOSE 22 0.0003
944 EYE PAIN 17 0.0003
945 AGGRESSION 15 0.0003
946 TYPE 2 DIABETES MELLITUS 10 0.0003
947 DRUG ADMINISTRATION ERROR 9 0.0003
948 BLOOD GLUCOSE DECREASED 14 0.0003
949 DELIRIUM 10 0.0003
950 NEOPLASM PROGRESSION 10 0.0003
951 DRUG-INDUCED LIVER INJURY 9 0.0003
952 NIGHT SWEATS 9 0.0003
953 LACTIC ACIDOSIS 9 0.0003
954 PRODUCT SUBSTITUTION ISSUE 16 0.0003
955 OSTEONECROSIS 9 0.0003
956 BLINDNESS 11 0.0003
957 DIPLOPIA 7 0.0003
958 THERAPEUTIC RESPONSE UNEXPECTED 12 0.0003
959 CARDIAC DISORDER 25 0.0003
960 MALIGNANT NEOPLASM PROGRESSION 27 0.0003
961 EAR INFECTION 7 0.0003
962 NO ADVERSE EVENT 46 0.0003
963 HALLUCINATION 19 0.0003
964 PRODUCT STORAGE ERROR 22 0.0003
965 DEMENTIA 7 0.0003
966 MYELOSUPPRESSION 9 0.0002
967 INCORRECT DRUG ADMINISTRATION DURATION 7 0.0002
968 EYE DISORDER 8 0.0002
969 INJECTION SITE PRURITUS 16 0.0002
970 ECZEMA 12 0.0002
971 EMOTIONAL DISORDER 7 0.0002
972 MEMORY IMPAIRMENT 30 0.0002
973 INJECTION SITE MASS 8 0.0002
974 POLLAKIURIA 9 0.0002
975 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
976 ANGER 7 0.0002
977 DISTURBANCE IN ATTENTION 11 0.0002
978 IRRITABILITY 12 0.0002
979 HYPOACUSIS 8 0.0002
980 PRODUCT DOSE OMISSION 12 0.0002
981 DRUG EFFECT DECREASED 9 0.0002
982 TOXICITY TO VARIOUS AGENTS 26 0.0002
983 SURGERY 9 0.0002
984 DEPRESSED MOOD 8 0.0002
985 COMPLETED SUICIDE 12 0.0001
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 28 0.0001
987 PROSTATE CANCER 10 0.0001
988 EYE IRRITATION 7 0.0001
989 DEVICE MALFUNCTION 8 0.0001
990 DEVICE DIFFICULT TO USE 7 0.0001
991 ACNE 8 0.0001
992 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
993 BREAST CANCER 7 0.0001
994 DRUG DEPENDENCE 10 0.0001
995 DRUG DOSE OMISSION 10 0.0001